Overview
Basic information about this protein and its source genome.
- Accession
- PA3092
- Gene
- fadH1 PA3092
- Status
- annotated
- Amino acids
- 679
- Structure source
- AlphaFold
Target profile
Computed evidence for target prioritization.
- Human off-target
- No hit
- Gut microbiome off-target
- hit
- Essential (DEG)
- Y
- Localization
- Cytoplasmic
Selected Druggability evidence
Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.
Sequence
Primary amino-acid sequence viewer.
Functional Annotations
Enzyme classification and Gene Ontology terms linked to this protein.
Gene Ontology (GO)
6- GO:0008670 Catalysis of the reactions: a 4,5-saturated-(2E)-enoyl-CoA + NADP+ = a (2E,4E)-dienoyl-CoA + H+ + NADPH, and a (2E,4Z)-dienoyl-CoA + H+ + NADPH = a 4,5-saturated-(2E)-enoyl-CoA + NADP+.
- GO:0010181 Binding to flavin mono nucleotide. Flavin mono nucleotide (FMN) is the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.
- GO:0051536 Binding to an iron-sulfur cluster, a combination of iron and sulfur atoms.
- GO:0046872 Binding to a metal ion.
- GO:0033543 A fatty acid beta-oxidation pathway by which fatty acids having cis-double bonds on even-numbered carbons are degraded. In this pathway, the intermediate 2,4-dienoyl-CoA is converted to trans-2-enoyl-CoA by 2,4-dienoyl-CoA reductase and delta3-delta2-enoyl-CoA isomerase; trans-2-enoyl-CoA returns to the core beta-oxidation pathway for further degradation. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).
- GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
Sequence Features
Domain/signature hits from InterPro and related databases.
Show feature table
| Start | End | DB | Term | Name |
|---|---|---|---|---|
| 625 | 641 | PRINTS | PR00368 | FAD-dependent pyridine nucleotide reductase signature |
| 503 | 521 | PRINTS | PR00368 | FAD-dependent pyridine nucleotide reductase signature |
| 463 | 481 | PRINTS | PR00368 | FAD-dependent pyridine nucleotide reductase signature |
| 381 | 400 | PRINTS | PR00368 | FAD-dependent pyridine nucleotide reductase signature |
| 466 | 657 | SUPERFAMILY | SSF51905 | FAD/NAD(P)-binding domain |
| 466 | 657 | InterPro | IPR036188 | FAD/NAD(P)-binding domain superfamily |
| 4 | 366 | SUPERFAMILY | SSF51395 | FMN-linked oxidoreductases |
| 475 | 632 | FunFam | G3DSA:3.50.50.60:FF:000113 | NADPH-dependent 2,4-dienoyl-CoA reductase |
| 475 | 632 | Gene3D | G3DSA:3.50.50.60 | - |
| 475 | 632 | InterPro | IPR036188 | FAD/NAD(P)-binding domain superfamily |
| 378 | 672 | Gene3D | G3DSA:3.40.50.720 | - |
| 379 | 642 | Pfam | PF07992 | Pyridine nucleotide-disulphide oxidoreductase |
| 379 | 642 | InterPro | IPR023753 | FAD/NAD(P)-binding domain |
| 6 | 373 | Gene3D | G3DSA:3.20.20.70 | Aldolase class I |
| 6 | 373 | InterPro | IPR013785 | Aldolase-type TIM barrel |
| 6 | 373 | FunFam | G3DSA:3.20.20.70:FF:000082 | NADPH-dependent 2,4-dienoyl-CoA reductase |
| 10 | 332 | Pfam | PF00724 | NADH:flavin oxidoreductase / NADH oxidase family |
| 10 | 332 | InterPro | IPR001155 | NADH:flavin oxidoreductase/NADH oxidase, N-terminal |
| 10 | 362 | CDD | cd02930 | DCR_FMN |
| 626 | 640 | PRINTS | PR00411 | Pyridine nucleotide disulphide reductase class-I signature |
| 380 | 402 | PRINTS | PR00411 | Pyridine nucleotide disulphide reductase class-I signature |
| 7 | 679 | PANTHER | PTHR42917 | 2,4-DIENOYL-COA REDUCTASE |
| 337 | 526 | SUPERFAMILY | SSF51971 | Nucleotide-binding domain |
3D Structure
Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.
Loading 3D structure...
Structural evidence
0 + 1Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.
| Entry | Method | Resolution | Chain | Coverage | Links | Status |
|---|---|---|---|---|---|---|
|
AlphaFold
PA3092
|
AlphaFold | — | — | full sequence | — | Viewing |
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer
Pockets (FPOCKET)
Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).
| FPOCKET | Sticks | Spheres | Surfaces | Druggability | Labels | Zoom | Positions |
|---|---|---|---|---|---|---|---|
| 2 | 0.529 |
Ligand evidence
Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.
Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in TPW, use Open crystal to inspect it in the structure viewer.
No PDB structure with a co-crystallized ligand found for this exact protein.
Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.
| Ligand | Source crystal | UniProt (homolog) | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|---|
| FLC | A0A0L8AFM7 | 189.1 Da LogP -5.25 TPSA 140.6 | ✓ Ro5 | ✓ Clean |
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O
|
|
| J5H | E1YD54 | 921.7 Da LogP 1.13 TPSA 363.6 | 3 viol. | ✓ Clean |
CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([…
|
|
| MDE | P42593 | 994.9 Da LogP 0.91 TPSA 382.6 | 3 viol. | ✓ Clean |
CCCCC[C@@H](C\C=C\C(=O)SCCNC(=O)CCNC(C(=O)C(C)(…
|
Experimental bioactivity from ChEMBL measured directly on this protein. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL bioactivity data found for this exact protein.
Bioactivity inferred from similar proteins in ChEMBL. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL hits found through similar proteins.
Proposed virtual-screening candidates from ZINC. Score = Tanimoto similarity to a known binder (0–1; higher = more similar).
No virtual-screening candidates for this protein.
PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.